Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 20 octobre 2023, 16:00 EDT / 22:00 CET Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth IRVINE, CA, et HERSTAL, BELGIQUE – 20 octobre 2023 – MDxHealth SA (NASDAQ/Euronext : MDXH) (“mdxhealth” ou la “Société“), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce […]
Mdxhealth’s New Share Capital Amount and New Number of Shares
NEWS RELEASE – REGULATED INFORMATION October 20, 2023, 4:00 PM EDT / 22:00 CET Mdxhealth’s New Share Capital Amount and New Number of Shares IRVINE, CA, and HERSTAL, BELGIUM – October 20, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today a announces, in accordance with Article […]
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL, BELGIUM – October 9, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today reported preliminary third quarter 2023 revenues, units, and cash position. For the third quarter […]
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONOCTOBER 2, 2023, 4:00pm ET / 22:00 CET MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting IRVINE, CA, and HERSTAL, BELGIUM – October 2, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision diagnostics […]
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer IRVINE, CA, and HERSTAL, BELGIUM – September 26, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision […]
MDxHealth communique ses résultats financiers T2 et S1 2023
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES 23 AOÛT 2023, 16 h 00 EDT, 22 h 00 CET MDxHealth communique ses résultats financiers T2 et S1 2023 Les revenus du T2 ont augmenté de 143 % par rapport à l’année dernière pour atteindre 16,7 millions de dollars ; si l’on exclut le GPS, les revenus ont augmenté de 29 % La marge brute du T2 a […]
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q2 and Half Year 2023 Results Year-over-year Q2 revenues increase by 143% to $16.7 million; excluding GPS, revenues up 29% Q2 gross margin expanded to 59.7% up from 42.4% in the prior year period Amended GPS purchase agreement with […]
MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
NEWS RELEASE10 AUGUST 2023, 4PM ET / 22:00 CET MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 Company to Host Conference Call with Live Q&A, August 23, 2023 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – August 10, 2023 – MDxHealth SA […]
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and Medicare AdvantageCoverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test Expansion of coverage with Cigna now includes full menu of Company’s precision diagnostic prostate cancer tests, representing more than 15 million lives under coverage IRVINE, CA, and HERSTAL, BELGIUM […]
MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION 30 June 2023, 10:00 p.m. CEST MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – 30 June 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today held an extraordinary general shareholders’ meeting (“EGM“). The items […]
